Serum Institute Halts India Trials Of Oxford Vaccine After Drug Controller's Notice tribuneindia.com

Trials paused after study participant developed unexplained illness The Serum Institute of India on Thursday announced halting of India trials of the Oxford University-AstraZeneca COVID vaccine candidate till the global suspension on the process is revoked and the trials restarted.